Gut Microbiota-Targeted Intervention of Hyperlipidemia Using <i>Monascus</i>-Fermented Ginseng
<b>Background/Objectives:</b> Hyperlipidemia (HLP) encompasses a spectrum of poorly understood lipid metabolism disorders that are frequently overlooked or misdiagnosed, potentially leading to multiple complications. While the gut microbiota has been implicated in HLP pathogenesis, the c...
Saved in:
| Main Authors: | Qing Zhou, Cuiting Yang, Mingyue Jia, Qingsong Qu, Xinhui Peng, Weishuo Ren, Guoqing Li, Yueyang Xie, Bingxuan Li, Xinyuan Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/5/661 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cholesterol-modulating effects of Korean red ginseng (KRG) targeting PCSK9 in hyperlipidemia
by: Chang Hwan Lee, et al.
Published: (2025-08-01) -
Characterization and Nutritional Intervention Effects of <i>Canna edulis</i> Type 5 Resistant Starch in Hyperlipidemia Mice
by: Houxier Li, et al.
Published: (2025-01-01) -
Microbial Fermentation Affects the Structure–Activity Relationship of Bioactive Compounds in Ginseng and Its Applications in Fermentation Products: A Review
by: Juan Bai, et al.
Published: (2025-07-01) -
Knowledge Mapping and Global Research Trends of Ginseng Polysaccharides: a Bibliometric Analysis with Visualizations from 1985 to 2023
by: Mo P, et al.
Published: (2025-04-01) -
Effects of fermented Arctium lappa L. root by Lactobacillus casei on hyperlipidemic mice
by: MingJu Chen, et al.
Published: (2024-10-01)